Relevance of neuropeptide Y for the neuroimmune crosstalk

Journal of Neuroimmunology

Volumn 134, Issue 1-2, 2003, Pages 1-11

  Bedoui, Sammy ^a   Kawamura, Noriyuki ^a   Straub, Rainer H ^b   Pabst, Reinhard ^c   Yamamura, Takashi ^a   Von Hörsten, Stephan ^c  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Autoimmunity; Co transmission; Immune functions; Infection; Leukocytes; Neuropeptide Y

Indexed keywords

CYTOKINE; NEUROPEPTIDE Y; NEUROTRANSMITTER; OXIDIZING AGENT;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CYTOKINE RELEASE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFECTION; INFLAMMATION; LEUKOCYTE MIGRATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; TH1 CELL; TH2 CELL;

ANIMALS; CATECHOLAMINES; HUMANS; IMMUNE SYSTEM; IMMUNE SYSTEM DISEASES; LEUKOCYTES; NEUROIMMUNOMODULATION; NEUROPEPTIDE Y; NEUROTRANSMITTER AGENTS; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 0037222949     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00424-1     Document Type: Review

References (103)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
2. Ahlborg G., Lundberg J.M. Exercise-induced changes in neuropeptide Y, noradrenaline and endothelin-1 levels in young people with type I diabetes. Clin. Physiol. 16:1996;645-655.
3. Ahmed M., Bjurholm A., Theodorsson E., Schultzberg M., Kreicbergs A. Neuropeptide Y- and vasoactive intestinal polypeptide-like immunoreactivity in adjuvant arthritis: effects of capsaicin treatment. Neuropeptides. 29:1995;33-43.
4. Ahmed A.A., Wahbi A., Nordlind K., Kharazmi A., Sundqvist K.G., Mutt V., Liden S. In vitro Leishmania major promastigote-induced macrophage migration is modulated by sensory and autonomic neuropeptides. Scand. J. Immunol. 48:1998;79-85.
5. Ahmed A.A., Wahbi A.H., Nordlin K. Neuropeptides modulate a murine monocyte/macrophage cell line capacity for phagocytosis and killing of Leishmania major parasites. Immunopharmacol. Immunotoxicol. 23:2001;397-409.
6. Alstergren P., Appelgren A., Appelgren B., Kopp S., Lundeberg T., Theodorsson E. Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis. Arch. Oral Biol. 40:1995;127-135.
7. Alstergren P., Appelgren A., Appelgren B., Kopp S., Lundeberg T., Theodorsson E. The effect on joint fluid concentration of neuropeptide Y by intra-articular injection of glucocorticoid in temporomandibular joint arthritis. Acta Odontol. Scand. 54:1996;1-7.
8. Andrade-Mena C.E. Inhibition of gamma interferon synthesis by catecholamines. J. Neuroimmunol. 76:1997;10-14.
9. Appelgren A., Appelgren B., Kopp S., Lundeberg T., Theodorsson E. Relation between the intra-articular temperature of the temporomandibular joint and the presence of neuropeptide Y-like immunoreactivity in the joint fluid. A clinical study. Acta Odontol. Scand. 51:1993;1-8.
10. Barbany G., Friedman W.J., Persson H. Lymphocyte-mediated regulation of neurotransmitter gene expression in rat sympathetic ganglia. J. Neuroimmunol. 32:1991;97-104.
11. Barnea A., Roberts J., Keller P., Word R.A. Interleukin-1beta induces expression of neuropeptide Y in primary astrocyte cultures in a cytokine-specific manner: induction in human but not rat astrocytes. Brain Res. 896:2001;137-145.
12. Bedoui S., Kuhlmann S., Nave H., Drube J., Pabst R., von Hörsten S. Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood: mobilization of B-1-like B-lymphocytes and activated monocytes. J. Neuroimmunol. 117:2001;125-132.
13. Bedoui S., Lechner S., Gebhardt T., Nave H., Beck-Sickinger A.G., Straub R.H., Pabst R., von Hörsten S. NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization. J. Neuroimmunol. 132:2002;25-33.
14. Belai A., Boulos P.B., Robson T., Burnstock G. Neurochemical coding in the small intestine of patients with Crohn's disease. Gut. 40:1997;767-774.
15. Benschop R.J., Rodriguez-Feuerhahn M., Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav. Immun. 10:1996;77-91.
16. Bjorck S., Jennische E., Dahlstrom A., Ahlman H. Influence of topical rectal application of drugs on dextran sulfate-induced colitis in rats. Dig. Dis. Sci. 42:1997;824-832.
17. Bracci-Laudiero L., Aloe L., Stenfors C., Tirassa P., Theodorsson E., Lundberg T. Nerve growth factor stimulates production of neuropeptide Y in human lymphocytes. NeuroReport. 7:1996;485-488.
18. Bracci-Laudiero L., Aloe L., Stenfors C., Theodorsson E., Lundeberg T. Development of systemic lupus erythematosus in mice is associated with alteration of neuropeptide concentrations in inflamed kidneys and immunoregulatory organs. Neurosci. Lett. 248:1998;97-100.
19. Cavallotti D., Artico M., Iannetti G., Cavallotti C. Occurrence of adrenergic nerve fibers in human thymus during immune response. Neurochem. Int. 40:2002;211-221.
20. Chelmicka-Schorr E., Checinski M., Arnason B.G. Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J. Neuroimmunol. 17:1988;347-350.
21. Crofford L.J., Engleberg N.C., Demitrack M.A. Neurohormonal perturbations in fibromyalgia. Bailliere's Clin. Rheumatol. 10:1996;365-378.
22. De la Fuente M., Bernaez I., Del Rio M., Hernanz A. Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY. Involvement of protein kinase C. Immunology. 80:1993;259-265.
23. De la Fuente M., Del Rio M., Medina S. Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions. J. Neuroimmunol. 116:2001;156-167.
24. D'Hooge R., De Deyn P.P., Verzwijvelen A., De Block J., De Potter W.P. Storage and fast transport of noradrenaline, dopamine beta-hydroxylase and neuropeptide Y in dog sciatic nerve axons. Life Sci. 47:1990;1851-1859.
25. Dimitrijevic M., Stanojevic S., Vujic V., Kovacevic-Jovanovic V., Beck-Sickinger A., Demuth H., von Hörsten S. Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26). J. Neuroimmunol. 129:2002;35-42.
26. Downing J.E., Miyan J.A. Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease. Immunol. Today. 21:2000;281-289.
27. Dureus P., Louis D., Grant A.V., Bilfinger T.V., Stefano G.B. Neuropeptide Y inhibits human and invertebrate immunocyte chemotaxis, chemokinesis, and spontaneous activation. Cell. Mol. Neurobiol. 13:1993;541-546.
28. Ekblad E., Edvinsson L., Wahlestedt C., Uddman R., Hakanson R., Sundler F. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul. Pept. 8:1984;225-235.
29. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52:2000;595-638.
30. Elitsur Y., Luk G.D., Colberg M., Gesell M.S., Dosescu J., Moshier J.A. Neuropeptide Y (NPY) enhances proliferation of human colonic lamina propria lymphocytes. Neuropeptides. 26:1994;289-295.
31. Ericsson A., Schalling M., McIntyre K.R., Lundberg J.M., Larhammar D., Seroogy K., Hokfelt T., Persson H. Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice. Proc. Natl. Acad. Sci. U. S. A. 84:1987;5585-5589.
32. Ericsson A., Hemsen A., Lundberg J.M., Persson H. Detection of neuropeptide Y-like immunoreactivity and messenger RNA in rat platelets: the effects of vinblastine, reserpine, and dexamethasone on NPY expression in blood cells. Exp. Cell Res. 192:1991;604-611.
33. Eruklar S.D. Siegel G.J., Agranoff B.W., Albers R., Molinoff P.B. Basic Neurochemistry. Molecular, Cellular and Medical Aspects. 1994;181-208 Raven Press, New York.
34. Fagerstam J.P., Whiss P.A., Strom M., Andersson R.G. Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease. Inflamm. Res. 49:2000;466-472.
35. Feher E., Zelles T., Nagy G. Immunocytochemical localisation of neuropeptide-containing nerve fibres in human labial glands. Arch. Oral Biol. 44(Suppl. 1):1999;S33-S37.
36. Felten S.Y., Olschowka J. Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic like contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res. 18:1987;37-48.
37. Felten D.L., Felten S.Y., Carlson S.L., Olschowka J.A., Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 135:1985;755s-765s.
38. Fried G., Terenius L., Hokfelt T., Goldstein M. Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat vas deferens. J. Neurosci. 5:1985;450-458.
39. Friedman E.M., Irwin M.R., Nonogaki K. Neuropeptide Y inhibits in vivo specific antibody production in rats. Brain Behav. Immun. 9:1995;182-189.
40. Grau V., Scriba A., Stehling O., Steiniger B. Monocytes in the rat. Immunobiology. 202:2000;94-103.
41. Hauser G.J., Myers A.K., Dayao E.K., Zukowska-Grojec Z. Neuropeptide Y infusion improves hemodynamics and survival in rat endotoxic shock. Am. J. Physiol. 265:1993;H1416-H1423.
42. Hernanz A., Tato E., De la F.M., de Miguel E., Arnalich F. Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha production by whole blood cells from healthy young and old subjects. J. Neuroimmunol. 71:1996;25-30.
43. Herzenberg L.A. B-1 cells: the lineage question revisited. Immunol. Rev. 175:2000;9-22.
44. Hökfelt T. Neuropeptides in perspective: the last ten years. Neuron. 7:1991;867-879.
45. Irwin M., Daniels M., Bloom E.T., Smith T.L., Weiner H. Life events, depressive symptoms, and immune function. Am. J. Psychiatry. 144:1987;437-441.
46. Irwin M., Brown M., Patterson T., Hauger R., Mascovich A., Grant I. Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J. 5:1991;3100-3107.
47. Jarek M.J., Legare E.J., McDermott M.T., Merenich J.A., Kollef M.H. Endocrine profiles for outcome prediction from the intensive care unit. Crit. Care Med. 21:1993;543-550.
48. Jindal N., Hollenberg S.M., Dellinger R.P. Pharmacologic issues in the management of septic shock. Crit. Care Clin. 16:2000;233-249.
49. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20:1999;68-100.
50. Kask A., Harro J., von Horsten S., Redrobe J.P., Dumont Y., Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci. Biobehav. Rev. 26:2002;259-283.
51. Kawamura N., Tamura H., Obana S., Wenner M., Ishikawa T., Nakata A., Yamamoto H. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation. 5:1998;9-15.
52. Kiecolt-Glaser J.K., Ricker D., George J., Messick G., Speicher C.E., Garner W., Glaser R. Urinary cortisol levels, cellular immunocompetency, and loneliness in psychiatric inpatients. Psychosom. Med. 46:1984;15-23.
53. Kohm A.P., Sanders V.M. Norepinephrine and Beta2-adrenergic receptor stimulation regulate CD4+T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 53:2001;487-525.
54. Konttinen Y.T., Hukkanen M., Kemppinen P., Segerberg M., Sorsa T., Malmstrom M., Rose S., Itescu S., Polak J.M. Peptide-containing nerves in labial salivary glands in Sjogren's syndrome. Arthritis Rheum. 35:1992;815-820.
55. Larsson J., Ekblom A., Henriksson K., Lundeberg T., Theodorsson E. Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand. J. Rheumatol. 20:1991;326-335.
56. Levite M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc. Natl. Acad. Sci. U. S. A. 95:1998;12544-12549.
57. Levite M., Cahalon L., Hershkoviz R., Steinman L., Lider O. Neuropeptides, via specific receptors, regulate T cell adhesion to fibronectin. J. Immunol. 160:1998;993-1000.
58. Lundberg J.M. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol. Rev. 48:1996;113-178.
59. Lundberg J.M., Rudehill A., Sollevi A., Fried G., Wallin G. Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport. Neuroscience. 28:1989;475-486.
60. Madden K.S. Catecholamines, sympathetic nerves, and immunity. Ader R., Felten D.L., Cohen N. Psychoneuroimmunology. 2001;197-230 Academic Press, San Diego.
61. Maeda K., Yasuda M., Kaneda H., Maeda S., Yamadori A. Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man. Neuropeptides. 27:1994;323-332.
62. Maisel A.S., Fowler P., Rearden A., Motulsky H.J., Michel M.C. A new method for isolation of human lymphocyte subsets reveals differential regulation of beta-adrenergic receptors by terbutaline treatment. Clin. Pharmacol. Ther. 46:1989;429-439.
63. Makhlouf K., Comabella M., Imitola J., Weiner H.L., Khoury S.J. Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis. J. Neuroimmunol. 117:2001;156-165.
64. Mapp P.I., Kidd B.L., Gibson S.J., Terry J.M., Revell P.A., Ibrahim N.B., Blake D.R., Polak J.M. Substance P-, calcitonin gene-related peptide-and c-flanking peptide of neuropeptide Y ir-fibers are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience. 37:1990;143-153.
65. Medina S., Del Rio M., Ferrandez M.D., Hernanz A., de la Fuente Changes with age in the modulation of natural killer activity of murine leukocytes by gastrin-releasing peptide, neuropeptide Y and sulfated cholecystokinin octapeptide. Neuropeptides. 32:1998;549-555.
66. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50:1998;143-150.
67. Miller L.E., Justen H.P., Scholmerich J., Straub R.H. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J. 14:2000;2097-2107.
68. Miyamoto K., Miyake S., Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature. 413:2001;531-534.
69. Mormède P., Dallman M.F., Fuchs E., Heijnen J.J., Heim C., Hellhammer D.H., Irwin M.S., Paykel E.S., von Holst D., Hörsten S.V. Pathological consequences of stress. Broom D.M. Coping With Challenge: Welfare in Animals Including Humans. 2001;337-356 Dahlem Univ. Press, Berlin.
70. Morris M.J., Pavia J.M. Stimulation of neuropeptide Y overflow in the rat paraventricular nucleus by corticotropin-releasing factor. J. Neurochem. 71:1998;1519-1524.
71. Nair M.P., Schwartz S.A., Wu K., Kronfol Z. Effect of neuropeptide Y on natural killer activity of normal human lymphocytes. Brain Behav. Immun. 7:1993;70-78.
72. Nissalo S., Hietanen J., Malmstrom M., Hukkanen M., Polak J., Konttinen Y.T. Disorder-specific changes in innervation in oral lichen planus and lichenoid reactions. J. Oral Pathol. & Med. 29:2000;361-369.
73. Ohia S.E., Jumblatt J.E. Inhibitory effects of neuropeptide Y on sympathetic neurotransmission in the rabbit iris-ciliary body. Neurochem. Res. 15:1990;251-256.
74. Pal E., Yamamura T., Tabira T. Autonomic regulation of experimental autoimmune encephalomyelitis in IL-4 knockout mice. J. Neuroimmunol. 100:1999;149-155.
75. Panina-Bordignon P., Mazzeo D., Lucia P.D., D'Ambrosio D., Lang R., Fabbri L., Self C., Sinigaglia F. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100:1997;1513-1519.
76. Paul W.E. Fundamental Immunology. 1998;245 Lippincott-Raven, New York.
77. Pellieux C., Sauthier T., Domenighetti A., Marsh D.J., Palmiter R.D., Brunner H.R., Pedrazzini T. Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors. Proc. Natl. Acad. Sci. U. S. A. 97:2000;1595-1600.
78. Pernow J., Schwieler J., Kahan T., Hjemdahl P., Oberle J., Wallin B.G., Lundberg J.M. Influence of sympathetic discharge pattern on norepinephrine and neuropeptide Y release. Am. J. Physiol. 257:1989;H866-H872.
79. Petitto J.M., Huang Z., McCarthy D.B. Molecular cloning of NPY-Y1 receptor cDNA from rat splenic lymphocytes: evidence of low levels of mRNA expression and [125I]NPY binding sites. J. Neuroimmunol. 54:1994;81-86.
80. Santavirta N., Konttinen Y.T., Tornwall J., Segerberg M., Santavirta S., Matucci-Cerinic M., Bjorvell H. Neuropeptides of the autonomic nervous system in Sjogren's syndrome. Ann. Rheum. Dis. 56:1997;737-740.
81. Schwarz H., Villiger P.M., von Kempis J., Lotz M. Neuropeptide Y is an inducible gene in the human immune system. J. Neuroimmunol. 51:1994;53-61.
82. Scriba A., Schneider M., Grau V., van der Meide P.H., Steiniger B. Rat monocytes up-regulate NKR-P1A and down-modulate CD4 and CD43 during activation in vivo: monocyte subpopulations in normal and IFN-gamma-treated rats. J. Leukoc. Biol. 62:1997;741-752.
83. Severn A., Rapson N.T., Hunter C.A., Liew F.Y. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J. Immunol. 148:1992;3441-3445.
84. Soder O., Hellstrom P.M. Neuropeptide regulation of human thymocyte, guinea pig T lymphocyte and rat B lymphocyte mitogenesis. Int. Arch. Allergy Appl. Immunol. 84:1987;205-211.
85. Song C., Leonard B.E. Comparison between the effects of sigma receptor ligand JO 1784 and neuropeptide Y on immune functions. Eur. J. Pharmacol. 345:1998;79-87.
86. Straub R.H., Herrmann M., Frauenholz T., Berkmiller G., Lang B., Schölmerich J., Falk W. Neuroimmune control of interleukin-6 secretion in the murine spleen. Differential beta-adrenergic effects of electrically released endogenous norepinephrine under various endotoxin conditions. J. Neuroimmunol. 71:1996;37-43.
87. Straub R.H., Westermann J., Schölmerich J., Falk W. Dialogue between the CNS and the immune system in lymphoid organs. Immunol. Today. 19:1998;409-413.
88. Straub R.H., Schaller T., Miller L.E., von Horsten S., Jessop D.S., Falk W., Schölmerich J. Neuropeptide Y cotransmission with norepinephrine in the sympathetic nerve-macrophage interplay. J. Neurochem. 75:2000;2464-2471.
89. Straub R.H., Mayer M., Kreutz M., Leeb S., Schölmerich J., Falk W. Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J. Leukoc. Biol. 67:2000;553-558.
90. Straub R.H., Linde H.J., Mannel D.N., Scholmerich J., Falk W. A bacteria-induced switch of sympathetic effector mechanisms augments local inhibition of TNF-alpha and IL-6 secretion in the spleen. FASEB J. 14:2000;1380-1388.
91. Straub R.H., Herfarth H., Falk W., Andus T., Scholmerich J. Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease? J. Neuroimmunol. 126:2002;116-125.
92. Sung C.P., Arleth A.J., Feuerstein G.Z. Neuropeptide Y upregulates the adhesiveness of human endothelial cells for leukocytes. Circ. Res. 68:1991;314-318.
93. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296:1982;659-660.
94. van der Poll T., Coyle S.M., Barbosa K., Braxton C.C., Lowry S.F. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest. 97:1996;713-719.
95. von Hörsten S., Nave H., Ballof J., Helfritz F., Meyer D., Schmidt R.E., Stalp M., Exton N.G., Exton M.S., Straub R.H., Radulovic J., Pabst R. Centrally applied NPY mimics immunoactivation induced by non-analgesic doses of met-enkephalin. NeuroReport. 9:1998;3881-3885.
96. von Hörsten S., Ballof J., Helfritz F., Nave H., Meyer D., Schmidt R.E., Stalp M., Klemm A., Tschernig T., Pabst R. Modulation of innate immune functions by intracerebroventricularly applied neuropeptide Y: dose and time dependent effects. Life Sci. 63:1998;909-922.
97. von Hörsten S., Exton N.G., Exton M.S., Helfritz F., Nave H., Ballof J., Stalp M., Pabst R. Brain NPY Y1 receptors rapidly mediate the behavioral response to novelty and a compartment-specific modulation of granulocyte function in blood and spleen. Brain Res. 806:1998;282-286.
98. Vezzani A., Sperk G., Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 22:1999;25-30.
99. Wahlestedt C., Edvinsson L., Ekblad E., Hakanson R. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J. Pharmacol. Exp. Ther. 234:1985;735-741.
100. Walker P., Grouzmann E., Burnier M., Waeber B. The role of neuropeptide Y in cardiovascular regulation. Trends Pharmacol. Sci. 12:1991;111-115.
101. Westermann J., Pabst R. Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? Immunol. Today. 11:1990;406-410.
102. Wiegmann K., Muthyala S., Kim D.H., Arnason B.G., Chelmicka-Schorr E. Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J. Neuroimmunol. 56:1995;201-206.
103. Woiciechowsky C., Asadullah K., Nestler D., Eberhardt B., Platzer C., Schoning B., Glockner F., Lanksch W.R., Volk H.D., Docke W.D. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat. Med. 4:1998;808-813.